Avoiding regulatory setbacks in OSD development

Avoiding regulatory setbacks in OSD development: Why early formulation decisions matter

Early formulation missteps in OSD formulation development can have a major negative impact on long-term goals and success. Learn how to navigate these risks and make the most of strategic CDMO partnerships.

Smart planning for expedited research

Pharma Ignite and Thermo Fisher Scientific examine the impacts of short-sighted planning in OSD formulation and offer insights into how a vision-led approach can make all the difference.

Read the blog now to learn more about:

The often-overlooked risks of rushing to FIH
The downstream impact of early decisions on CMC readiness for regulatory milestones and scale-up
Reducing the risk of formulation and regulatory setbacks by using strategic CDMO partnerships
Combining the right tools with scientific and regulatory insight for better risk mitigation and time management
Achieving clarity in early development: Questions to ask before formulation
Building for what comes next

Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.

By accessing this content, you are permitting Pharma Ignite or a third party to contact you regarding the content (by phone or email).